Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist
Can I Use the Combo on Other Body Parts
This phase 2 study showed promising results, but the study was small and only included 52 participants
Thus, without going into too many methodological details, there are questions about whether or not the approach used in this study fully explored (or rules out) the role of GLP-1 in the hypoglycaemic response
US$ 20.72
US$ 28.89
US$ 28.11
US$ 24.28
US$ 29.40
US$ 27.86
US$ 21.85
US$ 23.39
US$ 28.45
US$ 26.02
